Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

1(25%)

Results Posted

50%(1 trials)

Phase Distribution

Ph not_applicable

75%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

N/ANon-phased studies

3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(2)

Other(1)

Detailed Status

Completed2

Active, not recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

active_not_recruiting125%

completed250%

unknown125%

Recent Activity

1 active trials

Showing 4 of 4

active_not_recruitingnot_applicable

NET Device for Treating Opioid Use Disorder

NCT04916600

completed

Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Patients

NCT05671107

completednot_applicable

Immunological Changes Through Narrative Treatment of Post-Traumatic Stress Disorder (PTSD) in Torture Victims

NCT01206790

unknownnot_applicable

Change of Neural Network Indicators Through Narrative Treatment of PTSD in Torture Victims

NCT00563888

Clinical Trials (4)

Showing 4 of 4 trials

NCT04916600Not Applicable

NET Device for Treating Opioid Use Disorder

Active Not Recruiting

NCT05671107

Development and Validation of an Online Neurobehavioral Evaluation Tool for PTEN Patients

Completed

NCT01206790Not Applicable

Immunological Changes Through Narrative Treatment of Post-Traumatic Stress Disorder (PTSD) in Torture Victims

Completed

NCT00563888Not Applicable

Change of Neural Network Indicators Through Narrative Treatment of PTSD in Torture Victims

Unknown

All 4 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 4